Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bié provinces, central Angola

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 99, Issue 7, 2005, Pages 485-492

  Guthmann, Jean Paul ^a   Ampuero, Julia ^b,c   Fortes, Filomeno ^d   van Overmeir, Chantal ^e   Gaboulaud, Valérie ^a   Tobback, Sophie ^c   Dunand, Jean ^f   Saraiva, Nilton ^d   Gillet, Philippe ^c   Franco, Joan ^b   Denoncin, Anne ^c   van Herp, Michel ^c   Balkan, Suna ^b   Dujardin, Jean Claude ^e   D'Alessandro, Umberto ^a   Legros, Dominique ^a  

^a EPICENTRE   (France)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c MÉDECINS SANS FRONTIÈRES   (Belgium)

^d Programa Nacional de Controle da Malária   (Angola)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Amodiaquine; Angola; Artemisinin based combinations; Chloroquine; Plasmodium falciparum; Sulfadoxine pyrimethamine

Indexed keywords

AMODIAQUINE; ARTEMISININ; ARTESUNATE; CHLOROQUINE; FANSIDAR;

ANEMIA; ANGOLA; ANTIMALARIAL ACTIVITY; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; REINFECTION; TREATMENT FAILURE; VOMITING;

AMODIAQUINE; ANGOLA; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SESQUITERPENES; SULFADOXINE; TREATMENT FAILURE;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 21044459137     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2004.11.010     Document Type: Article

References (23)

1. Bloland, P.B., 2001. Drug Resistance in Malaria. World Health Organization, Geneva, WHO/CDS/CSR/DRS/2001.4.
2. P.B. Bloland M. Ettling S. Meek Combination therapy for malaria in Africa: Hype or hope? Bull. World Health Organ. 78 2003 1378-1388
3. B. Brabin Z. Premji F. Verhoeff Iron-deficiency anemia: Reexamining the nature and magnitude of the public health problem. An analysis of anemia and child mortality J. Nutr. 31 2001 636S-648S
4. F. Checchi P. Piola C. Kàsack E. Ardizzoni D. Klarkowski E. Kwezi G. Priotto S. Balkan N. Bakyaita A. Brockman J.-P. Guthmann Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine, and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda Trop. Med. Int. Health 9 2004 445-450
5. U. D'Alessandro H. Buttiëns History and importance of antimalarial drug resistance Trop. Med. Int. Health 6 2001 845-848
6. G. Dorsey D. Njama M.R. Kamya A. Cattamanchi D. Kyabayinze S.G. Staedke A. Gasasira P.J. Rosenthal Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: A longitudinal randomised trial Lancet 360 2002 2031-2038
7. A. Irion I. Felger S. Abdulla T. Smith R. Mull M. Tanner C. Hatz H.P. Beck Distinction of recrudescences from new infection by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children Trop. Med. Int. Health 3 1998 490-497
8. H. Kyronseppa J. Lumio R. Ukkonen T. Pettersson Chloroquine-resistant malaria from Angola Lancet 1 1984 1244
9. Laureillard, D., Fauveau, C., Bonte, L., Perea, W., 1996. Etude de la resistance du Plasmodium falciparum a la chloroquine et a la sulfadoxine-pyrimethamine. MSF-F, Benguela, Internal Report.
10. J. Lindberg T. Sandberg B. Bjorkholm Chloroquine and Fansidar resistant malaria acquired in Angola Lancet 1 1985 765
11. R. Martinez A. Perez J. Perez A. Ruiz O. Lazo Paludismo por Plasmodium falciparum resistente a las 4 aminoquinoleinas. Informe del primer caso importado de la Republica Popular de Angola Rev. Cubana Med. Trop. 37 1985 2-6
12. MINSA, 2001. Programa Nacional de Controle da Malária. Ministério da Saúde de Angola, Boletim Informativo, Abril.
13. F. Nosten P. Brasseur Combination therapy for malaria: The way forward Drugs 69 2002 1315-1329
14. E. Peña F. Rodriguez J. Pividal Paludismo importado en Cuba. Algunas consideraciones sobre su epidemiologia, vigilancia y control Rev. Cubana Med. Trop. 40 1988 82-96
15. K. Stepniewska W.R.J. Taylor M. Mayxay F. Smithuis J.-P. Guthmann K. Barnes H.Y. Myint P. Olliaro S. Pukrittayakamee S. Looareesuwan T.T. Hien J. Farrar F. Nosten N.P.J. Day N.J. White The in vivo assessment of antimalarial drug efficacy in falciparum malaria: The duration of follow-up Antimicrob. Agents Chemother. 48 2004 4271-4280
16. E. Stivanello P. Cavailler F. Cassano S.A. Omar D. Kariuki J. Mwangi P. Piola J.P. Guthmann Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county Sudan. Trop. Med. Int. Health 9 2004 975-980
17. S.D. Suleimanov Drug-resistant tropical malaria in Angola Med. Parazitol. 2 1994 8-10
18. N.J. White The assessment of antimalarial drug efficacy Trends Parasitol. 18 2002 458-464
19. WHO Basic Malaria Microscopy, Part I & II 1991 World Health Organization Geneva
20. WHO Severe falciparum malaria Trans. R. Soc. Trop. Med. Hyg. 94 Suppl. 1 2000
21. WHO, 2002. Monitoring antimalarial drug resistance. World Health Organization, Geneva, WHO/CDS/RBM/2002.39, WHO/CDS/EPH/2002.17.
22. WHO, 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. World Health Organization, Geneva, WHO/HTM/RBM/2003.5 0.
23. WHO/RBM, 2003. Position of WHO's Roll Back Malaria Department on malaria treatment policy, November 2003.